Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0180 | ||||
| Gene Name | SLC25A20 | ||||
| Protein Name | Carnitine/acylcarnitine translocase | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | CAC; CACT; Mitochondrial carnitine/acylcarnitine carrier protein; SLC25A20; Solute carrier family 25 member 20 | ||||
| DT Family | Mitochondrial Carrier (MC) Family ; | ||||
| Function | This transporter mediates the transport of acylcarnitines of different length across the mitochondrial inner membrane from the cytosol to the mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. | ||||
| Endogenous Substrate(s) | Acyl carnitine | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
L-carnitine
|
Approved | Drug Info | Nutritional deficiency | 5B7Z | [1] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 6 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Carnitine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| LysoPC(18:0) | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| LysoPC(20:1) | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| Palmitoylcarnitine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| Phytosphingosine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| Sphinganine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
| References | |||||
| 1 | Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. Hum Mutat. 2004 Oct;24(4):312-20. | ||||
| 2 | Serum metabolomics reveals that arsenic exposure disrupted lipid and amino acid metabolism in rats: a step forward in understanding chronic arsenic toxicity. Metallomics. 2015 Mar;7(3):544-52. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.